Publications by authors named "Jesus Corral"

29Publications

Anti-angiogenic agents in the age of resistance to immune checkpoint inhibitors: Do they have a role in non-oncogene-addicted non-small cell lung cancer?

Lung Cancer 2020 06 20;144:76-84. Epub 2020 Apr 20.

Boehringer Ingelheim International GmbH, Binger Strasse 173, 55216 Ingelheim am Rhein, Germany; Institute of Pharmacology, Johannes Gutenberg-University Mainz, 55122 Mainz, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2020.04.009DOI Listing
June 2020

PD-1/PD-L1 Blockers in NSCLC Brain Metastases: Challenging Paradigms and Clinical Practice.

Clin Cancer Res 2020 Aug 30;26(16):4186-4197. Epub 2020 Apr 30.

Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-20-0798DOI Listing
August 2020

Effects of dose modifications on the safety and efficacy of dacomitinib for mutation-positive non-small-cell lung cancer.

Future Oncol 2019 Aug 17;15(24):2795-2805. Epub 2019 Jul 17.

Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital & Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510080, PR China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2019-0299DOI Listing
August 2019

Management of common adverse events related to first-line dacomitinib use in mutation-positive non-small-cell lung cancer: a pooled safety analysis.

Future Oncol 2019 May 6;15(13):1481-1491. Epub 2019 Mar 6.

State Key Laboratory of South China, Department of Clinical Oncology, Chinese University of Hong Kong, Hong Kong, PR China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2018-0944DOI Listing
May 2019

A phase Ib study of sonidegib (LDE225), an oral small molecule inhibitor of smoothened or Hedgehog pathway, in combination with docetaxel in triple negative advanced breast cancer patients: GEICAM/2012-12 (EDALINE) study.

Invest New Drugs 2019 02 9;37(1):98-108. Epub 2018 Jun 9.

Department of Medical Oncology, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, C/Dr. Esquerdo 46, 28009, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-018-0614-9DOI Listing
February 2019

Improvement in Overall Survival in a Randomized Study That Compared Dacomitinib With Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer and EGFR-Activating Mutations.

J Clin Oncol 2018 08 4;36(22):2244-2250. Epub 2018 Jun 4.

Tony S. Mok, State Key Laboratory of South China, Chinese University of Hong Kong, Hong Kong; Ying Cheng, Jilin Provincial Cancer Hospital, Changchun; Xiangdong Zhou, First Affiliated Hospital of Third Military Medical University, Chongqing; Yi-Long Wu, Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China; Ki Hyeong Lee, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Korea; Kazuhiko Nakagawa, Kindai University Hospital, Osaka; Seiji Niho, National Cancer Center Hospital East, Kashiwa, Japan; Min Lee, SFJ Asia Pacific, Singapore; Rolf Linke, SFJ Pharmaceuticals Group, Pleasanton, CA; Rafael Rosell, Catalan Institute of Oncology, Barcelona; Jesus Corral, Hospital Universitario Virgen del Rocio, Seville, Spain; Maria Rita Migliorino, Pulmonary Oncology Unit, San Camillo-Forlanini Hospital, Rome, Italy; Adam Pluzanski, The Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland; Eric I. Sbar, Pfizer, Collegeville, PA; Tao Wang and Jane Liang White, Pfizer, Groton, CT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.78.7994DOI Listing
August 2018

Second-Line Treatment Selection in Patients With Non-Small-Cell Lung Cancer of Adenocarcinoma Histology: Findings From a European Survey of Treating Physicians.

Clin Lung Cancer 2017 03 26;18(2):e89-e97. Epub 2016 Oct 26.

Thoracic Oncology, Lungen Clinic Grosshansdorf, Member of the German Center for Lung Research, Grosshansdorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2016.10.004DOI Listing
March 2017

Efficacy of low doses of amphotericin B plus allicin against experimental visceral leishmaniasis.

J Antimicrob Chemother 2014 Dec 4;69(12):3268-74. Epub 2014 Aug 4.

Departamento de Sanidad Animal, Facultad de Veterinaria, Universidad Complutense de Madrid, Madrid, Spain

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dku290DOI Listing
December 2014

Treatment for early-stage lung cancer: what next?

Lancet 2014 May 25;383(9928):1528-30. Epub 2014 Feb 25.

Instituto de Biomedicina de Sevilla-IBIS, Servicio de Oncología Médica, Hospital Universitario Virgen del Rocío, 41013 Seville, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(14)60002-7DOI Listing
May 2014

FGF receptor inhibitors: role in cancer therapy.

Curr Oncol Rep 2012 Apr;14(2):111-9

Drug Development Unit, Division of Cancer Therapeutics, The Institute of Cancer Research/The Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey, SM2 5PT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-012-0225-0DOI Listing
April 2012

Sorafenib in metastatic thyroid cancer.

Endocr Relat Cancer 2012 Apr 10;19(2):209-16. Epub 2012 Apr 10.

Medical Oncology Department, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-11-0351DOI Listing
April 2012

Pathologic complete responses after chemotherapy plus figitumumab in stage IV non-small-cell lung cancer.

J Clin Oncol 2011 Mar 13;29(7):e163-5. Epub 2010 Dec 13.

Hospital Universitario Virgen del Rocío, Seville, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.31.4641DOI Listing
March 2011

Analysis of discrepancies in the interpretation of antiretroviral drug resistance results in HIV-1 infected patients of Basque Country, Spain.

J Clin Virol 2005 Jul 12;33(3):224-9. Epub 2005 Jan 12.

Viral Pathogenesis Department, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Carretera de Majadahonda a Pozuelo, 28220 Majadahonda, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcv.2004.06.014DOI Listing
July 2005